Bioactive peptides from marine sources as potential anti-inflammatory therapeutics

Current Protein and Peptide Science

Volumn 14, Issue 3, 2013, Pages 177-182

  Kim, Jung Ae ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Anti inflammation; Marine organism; Marine peptides

Indexed keywords

ACETYLSALICYLIC ACID; BIOACTIVE PEPTIDE; CELECOXIB; CYCLOMARIN; CYCLOPEPTIDE; HALIPEPTIN; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALYNGAMIDE F ACETATE; MALYNGAMIDE S; MICROCOLIN A; MITOGEN ACTIVATED PROTEIN KINASE; NAPROXEN; NITRIC OXIDE; PEPTIDES AND PROTEINS; PHYCOCYANIN; PROSTAGLANDIN SYNTHASE; ROFECOXIB; SALINAMIDE; SALINAMIDE A; SALINAMIDE B; SCYTONEMIN; SOLOMONAMIDE A; SOLOMONAMIDE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CYANOBACTERIUM; EDEMA; GRAM POSITIVE INFECTION; HUMAN; MARINE SPECIES; MICROALGA; NONHUMAN; OTITIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; AQUATIC ORGANISMS; CYANOBACTERIA; HUMANS; MICROALGAE; MOLECULAR SEQUENCE DATA; PEPTIDES; SMEGMAMORPHA;

EID: 84888218793     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990039     Document Type: Article

References (43)

1. Lordan, S.; Ross, R.P.; Stanton, C. Marine Bioactives as Functional Food Ingredients: Potential to Reduce the Incidence of Chronic Diseases. Mar. Drugs, 2011, 9, 1056-1100.
2. Rasmussen, R.S.; Morrissey, M.T. Marine biotechnology for production of food ingredients. Adv. Food Nutr. Res., 2007, 52, 237-292.
3. Plaza, M.; Cifuentes, A.; Ibáñez, E. In the search of new functional food ingredients from algae. Trends Food Sci. Technol., 2008, 19, 31-39.
4. Cragg, G.M.; Newman, D.J. Chemical diversity: a function of biodiversity. Trends Pharmacol. Sci., 2002, 23: 404-405.
5. Cragg, G.M.; Grothaus, P.G.; Newman, D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. ACS ASAP, 2009, 109, 3012-3043.
6. Villa, F.A.; Gerwick, L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immuopharm Immunot., 2010, 32, 228-237.
7. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature, 2008, 454, 436-444.
8. Villoslada, P.; Moreno, B.; Melero, I.; Pablos, J.L.; Martino, G.; Uccelli, A.; Montalban, X.; Avila, J.; Rivest, S.; Acarin, L.; Appel, S.; Khoury, S.; McGeer, P.; Ferrer, I.; Delgado, M.; Obeso, J. Schwartz M. Immunotherapy for neurological diseases. Clin. Immunol., 2008, 128, 294-305.
9. Aneiros, A.; Garateix, A. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J. Chromatogr. B., 2004, 803, 41-53.
10. Ferreira, S.H.; Vane, J.R. New aspects of the mode of action of Non steroid anti-inflammatory drugs. Ann. Rev. Pharmacol., 1974, 14, 57-73.
11. López, J.E.T.; Soto, V.G. Participación de la ciclooxigenasa-1 en el dolor inflamatorio. Universidad Juarez Autonoma de Tabasco Mexico, 2001, 17, 73-81.
12. Takei, M.; Burgoyne, D.L.; Andersen, R.J. Effect of contignasterol on histamine release induced by anti-immunoglobulin E from rat peritoneal mast cells. J. Pharm. Sci., 1994, 83, 1234-1235.
13. Strangman, W.K.; Kwon, H.C.; Broide, D.; Jensen, P.R.; Fenical, W. Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium. J. Medicl. Chem., 2009, 52, 2317-2327.
14. Edwards, D.J.; Marquez, B.L.; Nogle, L.M.; McPhail, K.; Goeger, D.E.; Roberts, M.A.; Gerwick, W.H. Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem. Biol., 2004, 11, 817-833.
15. Fenical, W.; Jensen, P.R. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat. Chem. Biol., 2006, 2, 666-673.
16. Beck, P.L.; Wallace, J.L. Cytokines in inflammatory bowel disease. Mediat. Inflamm., 1997, 6, 95-103.
17. Zhang, L.H.; Longley, R.E.; Koehn, F.E. Antiproliferative and immunosuppressive properties of microcolin A, a marine-derived lipopeptide. Life Sci., 1997, 60, 751-762.
18. Takamatsu, S.; Nagle, D.G.; Gerwick, W.H. Secondary metabolites from marine cyanobacteria and algae inhibit LFA-1/ICAM-1 mediated cell adhesion. Planta. Med., 2004, 70, 127-131.
19. Stevenson, C.S.; Capper, E.A.; Roshak, A.K.; Marquez, B.; Eichman, C.; Jackson, J.R.; Mattern, M.; Gerwick, W.H.; Jacobs, R.S. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J. Pharmacol. Exp. Ther., 2002, 303, 858-866.
20. Blumberg, P.M.; Acs, G.; Acs, P.; Areces, L.B.; Kazanietz, M.G.; Lewin, N.E.; Szallasi, Z. Protein kinase C in cell signaling: strategies for the development of selective inhibitors. Agents Actions Suppl., 1995, 47, 87-100.
21. Stevenson, C.S.; Capper, E.A.; Roshak, A.K.; Marquez, B.; Grace, K.; Gerwick, W.H.; Jacobs, R.S.; Marshall, L.A. cytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflammat. Res., 2002, 51, 112-114.
22. Appleton, D.R.; Sewell, M.A.; Berridge, M.V.; Copp, B.R. A new biologically active malyngamide from a New Zealand collection of the sea hare Bursatella leachii. J. Natural. Prods., 2002, 65, 630-631.
23. Jensen, P.R.; Williams, P.G.; Oh, D.C.; Zeigler, L.; Fenical, W. Species specific secondary metabolite production in marine actinomycetes of the Genus Salinispora. Appl. Environ. Microbiol., 2007, 73, 1146-1152.
24. Trischman, J.A.; Tapiolas, D.M.; Jensen, P.R.; Dwight, R.; Fenical, W.; McKee, T.C.; Ireland, C.M.; Stout, T.J.; Clardy, J. Salinamides A and B: anti-inflammatory depsipeptides from a marine Streptomycetes. J. Am. Chem. Soc., 1994, 116, 757-758.
25. Renner, M.K.; Shen, Y.C.; Cheng, X.C.; Jensen, P.R.; Frankmoelle, W.; Kauffman, C.A.; Fenical, W.; Lobkovsky, E.; Clardy, J. Cyclomarins A-C, New Antiinflammatory Cyclic Peptides Produced by a Marine Bacterium (Streptomyces sp.). J. Am. Chem. Soc., 1999, 121, 11273-11276.
26. Schmitt, E.K.; Riwanto, M.; Sambandamurthy, V.; Roggo, S.; Miault, C.; Zwingelstein, C.; Krastel, P.; Noble, C.; Beer, D.; Rao, S.P.S.; Au, M.; Niyomrattanakit, P.; Lim, V.; Zheng, J.; Jeffery, D.; Pethe, K.; Camacho, L.R. The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the Clp-C1 Subunit of the Caseinolytic Protease. Angew. Chem. Int. Ed., 2011, 50, 5889-5891.
27. Pietra, F. Secondary metabolites from marine microorganisms: bacteria, protozoa, algae and fungi. Achievements and prospects. Nat. Prod. Rep., 1997, 14, 453-464.
28. Moore, B.S.; Trischman, J.A.; Seng, D.; Kho, D.; Jensen, P.R.; Fenical, W. Salinamides, Antiinflammatory peptides from a Marine Streptomycete. J. Org. Chem., 1999, 64, 1145-1150.
29. Gawley, R.E.; Rein, K.S.; Kinoshita, M.; Baden, D.G. Binding of brevetoxins and ciguatoxin to the voltage-sensitive sodium channel and conformational analysis of brevetoxin B. Toxicon., 1992, 30, 780-785.
30. Weise, G.; Drews, G.; Jann, B.; Jann, K. Identification and analysis of a lipopolysaccharide in cell walls of blue-green alga Anacystisnidulans. Archiv. Fur. Mikrobiologie, 1970, 71, 89-98.
31. Festa, C.; De Marino, S.; D'Auria, M.V.; Monti, M.C.; Bucci, M.; Vellecco, V.; Debitus, C.; Zampella, A. Anti-inflammatory cyclopeptides from the marine sponge Theonella swinhoei. Tetrahedron, 2012, 68, 2851-2857.
32. Festa, C.; De Marino, S.; Sepe, V.; D'Auria, M.V.; Bifulco, G.; Cecile, D.; Bucci, M.; Vellecco, V.; Zampella, A. Solomonamides A and B, New Anti-inflammatory Peptides from Theonella swinhoei. Org. Lett., 2011, 13, 1532-1535.
33. Romay, C.H.; González, R.; Ledón, N.; Remirez, D.; Rimbau, V. C-Phycocyanin: A Biliprotein with Antioxidant, Anti-Inflammatory and Neuroprotective Effects. Curr. Protein Pept. Sci., 2003, 4, 207-216.
34. Romay, C.; Armesto, J.; Remirez, D.; Gonzalez, R.; Ledon, N.; Garcia, I. Antioxidant and anti-inflammatory properties of Cphycocyanin from blue-green algae. Inflammat. Res., 1998, 47, 36-41.
35. Remirez, D.; Gonzalez, R.; Merino, N.; Rodriguez, S.; Ancheta, O. Inhibitory effects of Spirulina in zymosan-induced arthritis in mice. Mediat. Inflamm., 2002, 11, 75-79.
36. Romay, C.H.; Led́on, N.; Gonźalez, R. Effects of phycocyanin extract on prostaglandin E2 levels in mouse ear inflammation test. Arzneim Forsch/ Drug Res., 2000, 50, 1106-1109
37. Gonźalez, R.; Rodŕõguez, S.; Romay, C.H.; Ancheta, O.; Gonźalez, A.; Armesto, J.; Remirez, D.; Merino, N. Antiinflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Pharmacol. Res., 1999, 39, 55-59.
38. Reddy, C.M.; Bhat, V.B.; Kiranmai, G.; Reddy, M.N.; Reddanna, P.; Madyastha, K.M. Selective inhibition of cyclooxygenase-2 by C-phocyanin, a biliprotein from Spirulina platensis. Biochem. Ciophys. Res. Commun., 2000, 277, 599-603.
39. Deng, R.; Chow, T.J. Hypolipidemic, Antioxidant and Antiinflammatory Activities of Microalgae Spirulina. Cardiovasc. Ther., 2010, 28, e33-e45.
40. Kim, H.M.; Lee, E.H.; Cho, H.H.; Moon, Y.H. Inhibitory effect of mast cell mediated immediate type allergic reactions in rats by spirulina. Biochem. Pharmacol., 1998, 55, 1071-1076.
41. Zhang, N.; Xu, B.; Mou, C.; Yang, W.; Wei, J.; Lu, L.; Zhu, J.; Du, J.; Wu, X.; Ye, L.; Fu, Z.; Lu, Y.; Lin, J.; Sun, Z.; Su, J.; Dong, M.; Xu, A. Molecular profile of the unique species of traditional Chinese medicine, Chinese seahorse (Hippocampus kuda Bleeker), FEBS Lett., 2003, 550, 124-134.
42. Hu, J.Y.; Li, B.F.; Li, Z.J.; Lu, P.P. An experimental study on antifatigue effects of eight marine pharmakons, Chin. J. Mar. Drugs, 2000, 2, 56-58.
43. Ryu, B.M.; Qian, Z.J.; Kim, S.K. Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-κB activation, and induces human osteoblastic and chondrocytic differentiation Chemico-Biolog. Interact., 2010, 184, 413-422.